Jedrzejczak W W, Szczylik C, Ratajczak M Z
Zakładu Immunologiii CSK WAM, Warszawie.
Pol Tyg Lek. 1993;48(25-26):543-5.
A health status of three long-term survivors (one--5 years, two--3 years) after the allogenic bone marrow transplantation from HLA-identical siblings is discussed. All bone marrow recipients are in excellent clinical condition, any transplant-related medication is given. All patients lead a normal life. No significant developmental, hematologic or metabolic disorders are observed except one patient in whom mild abnormalities in liver enzymes activity was noted. Successful bone marrow transplantation offers the recipients a normal life.
本文讨论了3例接受来自HLA相同同胞的异基因骨髓移植的长期存活者(1例存活5年,2例存活3年)的健康状况。所有骨髓接受者的临床状况良好,未服用任何与移植相关的药物。所有患者都过着正常生活。除1例患者的肝酶活性有轻微异常外,未观察到明显的发育、血液学或代谢紊乱。成功的骨髓移植使接受者能够过上正常生活。